|Articles|November 1, 2001
Is patients' rights bill victim of ailing economy?
In wake of reeling economy and terrorist tragedies, business lobbyistsconfident bill is dead for a year
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.